Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Craig Brooks, PhD, and colleagues are studying a molecular mechanism that promotes chronic kidney disease following kidney injury. (photo by Erin O. Smith)

December 15, 2022

Novel therapeutic target identified for chronic kidney disease

Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury.

By Leigh MacMillan

February 6, 2019

Katrina Robertson went from death’s door to a full life. Her story is one of thousands from the first 25 years of the Vanderbilt Comprehensive Care Clinic

The VCCC opened its doors 25 years ago when AIDS was fatal and hope was rare. Today the clinic serves thousands of patients and is an international model in the treatment of people with HIV.

By Wayne Wood

February 2, 2026

Pom-poms for a new era: Briceton Latta’s next cystic fibrosis chapter

When Briceton Latta was born in 2006, the average life expectancy of a patient with CF was 37. Today, that expectancy is 65 and beyond.

For Media

Voice

Magazines

Explore

Explore by Highlight

Explore by Topic

Explore by Location

March 4, 2019

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Related

Share:

Print: